StockData
Progyny, Inc. logo

Progyny, Inc. (PGNY) stock

PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.71−0.44 (-1.18%)

Close on Nov 17, 2026Market cap $2.82BP/E 39.9Yield –

Progyny price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Progyny's price to sales ratio was 2.2× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.1× to 9.6×, with a median of 2.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×+0.4
2025Dec 31, 20251.7×+0.4
2024Dec 31, 20241.3×−2.1
2023Dec 29, 20233.4×−0.7
2022Dec 30, 20224.1×−5.5
2021Dec 31, 20219.6×−2.3
2020Dec 31, 202011.8×+10.4
2019Dec 31, 20191.4×–

More Progyny figures

See a number that looks wrong?